The FDA's pregnancy safety designation of Category A for a drug means:
A) no adequate animal studies or adequate studies of pregnant women have been done.
B) animal studies have demonstrated adverse effects, but there are no adequate studies in pregnant women; benefits may be acceptable despite the potential risks.
C) adequate studies in pregnant women have not demonstrated a risk to the fetus in the first trimester or later trimesters.
D) fetal risk has been demonstrated, which outweighs any possible benefit to the mother; avoid using in pregnant or potentially pregnant patients.
Question 2
A patient informs you that he has had his gallbladder surgically removed. Based on the physiology of the gallbladder, which one of the following is true?
A) He may have difficulty digesting large amounts of fats.
B) He cannot store glycogen produced by the liver.
C) He will be more prone to gastric ulcers.
D) He must avoid meals high in complex carbohydrates.
The process of mitosis in an animal cell.
Liposomal amphotericin B: Drug molecules are embedded in the lipid bilayer.
Phases of Drug Development
Example of “drug facts” labeling on the box of an OTC drug.
Animal that offer potential medical uses
Postural changes with pregnancy in 28 weeks